Stay updated on Durvalumab Consolidation in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Consolidation in NSCLC Clinical Trial page.

Latest updates to the Durvalumab Consolidation in NSCLC Clinical Trial page
- Check7 days agoChange DetectedAdded Revision: v3.5.2. Deleted Revision: v3.5.0 from the history.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedAdded Record History and Study Record Versions with version-by-version details and a compare option, plus related UI elements (Results Posted, Researcher View, Study Details, Download, Save) to improve traceability of the trial record.SummaryDifference39%

- Check44 days agoChange DetectedRevision: v3.4.3 added; several history-related sections appear removed or hidden, with updated UI for versioning.SummaryDifference14%

- Check51 days agoChange DetectedA new Study Status entry was added on 2026-02-10 and an earlier entry was removed on 2025-11-10 in the record history.SummaryDifference0.2%

- Check58 days agoChange DetectedThe new version adds multiple study locations (and their contacts) and removes several previously listed locations. This updates the geographic coverage and contact points shown in the study record.SummaryDifference0.1%

- Check72 days agoChange DetectedThe page history shows a new revision label (v3.4.2) replacing v3.4.1, a minor site update that does not affect study data or user-facing content; to avoid alerts for small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Durvalumab Consolidation in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Consolidation in NSCLC Clinical Trial page.